SE348942B - - Google Patents

Info

Publication number
SE348942B
SE348942B SE763270A SE763270A SE348942B SE 348942 B SE348942 B SE 348942B SE 763270 A SE763270 A SE 763270A SE 763270 A SE763270 A SE 763270A SE 348942 B SE348942 B SE 348942B
Authority
SE
Sweden
Application number
SE763270A
Inventor
L Falksveden
Original Assignee
Statens Bakteriologiska Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Bakteriologiska Labor filed Critical Statens Bakteriologiska Labor
Priority to SE763270A priority Critical patent/SE348942B/xx
Priority to GB1784271A priority patent/GB1344340A/en
Priority to CA114,557A priority patent/CA960964A/en
Priority to DE19712127159 priority patent/DE2127159C2/en
Priority to CH793671A priority patent/CH572745A5/xx
Priority to AT471971A priority patent/AT309678B/en
Priority to NL7107529A priority patent/NL177599C/en
Priority to FR7119993A priority patent/FR2100716B1/fr
Publication of SE348942B publication Critical patent/SE348942B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE763270A 1970-06-02 1970-06-02 SE348942B (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE763270A SE348942B (en) 1970-06-02 1970-06-02
GB1784271A GB1344340A (en) 1970-06-02 1971-05-28 Method for fractionating plasma proteins
CA114,557A CA960964A (en) 1970-06-02 1971-06-01 Method for fractionating plasma proteins
DE19712127159 DE2127159C2 (en) 1970-06-02 1971-06-01 IgG immunoglobulin fraction and its production
CH793671A CH572745A5 (en) 1970-06-02 1971-06-01
AT471971A AT309678B (en) 1970-06-02 1971-06-01 Process for the production of immunoglobulin
NL7107529A NL177599C (en) 1970-06-02 1971-06-01 METHOD FOR EXTRACTING AND PURIFYING IMMUNOGLOBULIN G.
FR7119993A FR2100716B1 (en) 1970-06-02 1971-06-02

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE763270A SE348942B (en) 1970-06-02 1970-06-02

Publications (1)

Publication Number Publication Date
SE348942B true SE348942B (en) 1972-09-18

Family

ID=20271889

Family Applications (1)

Application Number Title Priority Date Filing Date
SE763270A SE348942B (en) 1970-06-02 1970-06-02

Country Status (8)

Country Link
AT (1) AT309678B (en)
CA (1) CA960964A (en)
CH (1) CH572745A5 (en)
DE (1) DE2127159C2 (en)
FR (1) FR2100716B1 (en)
GB (1) GB1344340A (en)
NL (1) NL177599C (en)
SE (1) SE348942B (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010138736A2 (en) 2009-05-27 2010-12-02 Baxter International Inc. A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
WO2011149472A1 (en) 2010-05-26 2011-12-01 Baxter International Inc. Method for preparing an enriched igg composition from plasma
WO2011150284A2 (en) 2010-05-26 2011-12-01 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
WO2013033042A1 (en) 2011-08-26 2013-03-07 Baxter International Inc. Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition
WO2013126904A1 (en) 2012-02-23 2013-08-29 Baxter International Inc. Fraction i-iv-1 precipitation of immunoglobins from plasma
WO2013130826A2 (en) 2012-02-29 2013-09-06 Baxter International Inc. Igg stimulated remyelination of peripheral nerves
WO2014134070A1 (en) 2013-02-26 2014-09-04 Baxter International Inc. Treatment of central nervous system disorders by intranasal administration of immunoglobulin g
WO2014182631A1 (en) 2013-05-06 2014-11-13 Baxter International Inc. Treatment of alzheimer's disease subpopulations with pooled immunoglobulin g
WO2023170553A1 (en) 2022-03-07 2023-09-14 Takeda Pharmaceutical Company Limited Affinity chromatographic production of clinical human igg products

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE389596B (en) * 1974-06-14 1976-11-15 P G S Lindroos SUGGESTED TO SEPARATE GLOBIN IRON COMPOUNDS FROM A VETICAL CONTAINING BLOOD SUBSTANCES
DE2500076C3 (en) * 1975-01-02 1982-11-18 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Process for the production of intravenously tolerated gamma globulins
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
AT359641B (en) * 1978-09-19 1980-11-25 Immuno Ag METHOD FOR PRODUCING AN INTRAVENOUS ADMINISTRABLE ANTIBODY-CONTAINING IMMUNOGLOBULIN PREPARATE
US4315851A (en) 1978-12-29 1982-02-16 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition having antitumor activity
EP2376523A4 (en) * 2009-01-13 2012-11-28 Ge Healthcare Bio Sciences Ab Precipitation of biomolecules with negatively charged polymers
IT1397061B1 (en) * 2009-12-28 2012-12-28 Kedrion Spa NEW PROCESS OF PURIFICATION ON INDUSTRIAL SCALE OF GAMMAGLOBULINE FROM HUMAN PLASMA FOR INDUSTRIAL USE.
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL286954A (en) * 1962-01-03
BE713764A (en) * 1967-05-01 1968-09-16 Baxter Travenol Lab
AT275038B (en) * 1967-11-15 1969-10-10 Immuno Ag Process for the production of pure blood albumin from protein solutions containing hemopigments

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3708581A1 (en) 2009-05-27 2020-09-16 Baxalta GmbH A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
US11242380B2 (en) 2009-05-27 2022-02-08 Takeda Pharmaceutical Company Limited Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
US8546548B2 (en) 2009-05-27 2013-10-01 Baxter International Inc. Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
US10125189B2 (en) 2009-05-27 2018-11-13 Baxalta Incorporated Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
WO2010138736A2 (en) 2009-05-27 2010-12-02 Baxter International Inc. A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
EP2554160A1 (en) 2010-05-26 2013-02-06 Baxter International Inc. Method for preparing an enriched IgG composition from plasma
EP4039249A1 (en) 2010-05-26 2022-08-10 Baxalta GmbH Removal of serine proteases by treatment with finely divided silicon dioxide
WO2011150284A2 (en) 2010-05-26 2011-12-01 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
US11891431B2 (en) 2010-05-26 2024-02-06 Takeda Pharm Limited ceutical Company Limited Removal of serine proteases by treatment with finely divided silicon dioxide
EP2796128A1 (en) 2010-05-26 2014-10-29 Baxter International Inc Enrichment of factor H out of plasma
US10875906B2 (en) 2010-05-26 2020-12-29 Baxalta Incorporated Removal of serine proteases by treatment with finely divided silicon dioxide
EP2803349A1 (en) 2010-05-26 2014-11-19 Baxter International Inc. Method for preparing an enriched IgG composition from plasma
US10208106B2 (en) 2010-05-26 2019-02-19 Baxalta Incorporated Removal of serine proteases by treatment with finely divided silicon dioxide
US9708391B2 (en) 2010-05-26 2017-07-18 Baxalta Incorporated Removal of serine proteases by treatment with finely divided silicon dioxide
WO2011149472A1 (en) 2010-05-26 2011-12-01 Baxter International Inc. Method for preparing an enriched igg composition from plasma
WO2013033042A1 (en) 2011-08-26 2013-03-07 Baxter International Inc. Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition
US9403899B2 (en) 2011-08-26 2016-08-02 Baxalta Incorporated Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition
WO2013126904A1 (en) 2012-02-23 2013-08-29 Baxter International Inc. Fraction i-iv-1 precipitation of immunoglobins from plasma
US9782477B2 (en) 2012-02-23 2017-10-10 Baxalta Incorporated Fraction I-IV-1 precipitation of immunoglobins from plasma
EP4119574A1 (en) 2012-02-23 2023-01-18 Takeda Pharmaceutical Company Limited Fraction i-iv-1 precipitation of immunoglobins from plasma
WO2013130826A2 (en) 2012-02-29 2013-09-06 Baxter International Inc. Igg stimulated remyelination of peripheral nerves
EP3590960A1 (en) 2012-02-29 2020-01-08 Baxalta GmbH Igg stimulated remyelination of peripheral nerves
EP3597220A1 (en) 2013-02-26 2020-01-22 Baxalta GmbH Treatment of central nervous system disorders by intranasal administration of immunoglobulin g
WO2014134070A1 (en) 2013-02-26 2014-09-04 Baxter International Inc. Treatment of central nervous system disorders by intranasal administration of immunoglobulin g
EP3552624A1 (en) 2013-05-06 2019-10-16 Baxalta Incorporated Treatment of alzheimer's disease subpopulations with pooled immunoglobulin g
WO2014182631A1 (en) 2013-05-06 2014-11-13 Baxter International Inc. Treatment of alzheimer's disease subpopulations with pooled immunoglobulin g
WO2023170553A1 (en) 2022-03-07 2023-09-14 Takeda Pharmaceutical Company Limited Affinity chromatographic production of clinical human igg products

Also Published As

Publication number Publication date
DE2127159C2 (en) 1981-12-24
FR2100716A1 (en) 1972-03-24
CA960964A (en) 1975-01-14
NL177599C (en) 1985-10-16
GB1344340A (en) 1974-01-23
DE2127159A1 (en) 1971-12-09
AT309678B (en) 1973-08-27
FR2100716B1 (en) 1975-06-06
CH572745A5 (en) 1976-02-27
NL177599B (en) 1985-05-17
NL7107529A (en) 1971-12-06

Similar Documents

Publication Publication Date Title
AR204384A1 (en)
FR2100716B1 (en)
ATA96471A (en)
AU1146470A (en)
AU1473870A (en)
AU2044470A (en)
AU2017870A (en)
AU1833270A (en)
AU2085370A (en)
AU1326870A (en)
AU1336970A (en)
AU1517670A (en)
AU1716970A (en)
AR195465A1 (en)
AU2112570A (en)
AU2119370A (en)
AU1689770A (en)
AU1789870A (en)
AU2115870A (en)
AU1328670A (en)
AU1603270A (en)
AU1832970A (en)
AU1004470A (en)
AU1343870A (en)
AU1277070A (en)